Acute Management of Optic Neuritis: An Evolving Paradigm

Area of Science:

• Neuroimmunology
• Ophthalmology
• Neurology

Background:

• Current acute optic neuritis (ON) treatment prioritizes rapid visual recovery using high-dose corticosteroids.
• Emerging research links specific autoantibodies to central nervous system inflammatory disorders, influencing ON prognosis and recurrence.

Purpose of the Study:

• To highlight the importance of recognizing clinical, laboratory, and imaging findings in optic neuritis.
• To emphasize the need for timely and precise diagnosis of inflammatory ON for optimized patient care.

Main Methods:

• Review of current management strategies for acute optic neuritis.
• Analysis of recent findings on autoantibodies in central nervous system inflammatory disorders.
• Integration of clinical, laboratory, and imaging data for etiological diagnosis.

Main Results:

• Specific autoantibodies offer new insights into ON pathogenesis and treatment targets.
• Awareness of diagnostic clues can guide neurologists and ophthalmologists toward more aggressive management when indicated.
• Early and accurate diagnosis is crucial for effective therapeutic interventions.

Conclusions:

• Understanding autoantibody profiles is key to managing optic neuritis effectively.
• A proactive diagnostic approach improves both short-term and long-term outcomes for patients with inflammatory ON.
• Neurologists and ophthalmologists must stay informed about advancements in ON diagnosis and treatment.